Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function

Fused cyclic compounds method of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.